Cellectar Biosciences (CLRB) Files 300k Common Stock Shelf for Selling Shareholders

October 24, 2016 9:25 AM EDT

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

Cellectar Biosciences (Nasdaq: CLRB) filed a registration with the U.S. SEC to sell up to 300,006 shares of common stock on behalf of selling shareholders.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Equity Offerings

Add Your Comment